Sign In
Buy IHE
$101.62
-0.84 (-0.82%)
At Close: Jul 31, 2026
5 ETFs to Buy for January
01:00pm, Thursday, 08'th Jan 2026
5 ETFs to buy in January: momentum, small caps, chips, defense and healthcare shine as markets rally early in 2026 -- IWM, MTUM, SMH, XAR and IHE.
Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)?
07:21am, Wednesday, 07'th Jan 2026
Looking for broad exposure to the Healthcare - Pharma segment of the equity market? You should consider the iShares U.S. Pharmaceuticals ETF (IHE), a passively managed exchange traded fund launched on
Bet on These Top-Ranked Healthcare ETFs Before 2025 Ends
02:46pm, Monday, 22'nd Dec 2025
XLV and similar healthcare ETFs are gaining momentum as strength in biotech, increased AI adoption, and rising defensive demand position the sector for year-end leadership.
Pharma's $370B Bet on America: The ETF Plays for 2026
01:16pm, Friday, 19'th Dec 2025
Pharma ETFs like IHE are gaining traction as drugmakers pledge $370 billion to U.S. projects, fueling a new investment super-cycle heading into 2026.
3 Dividend ETFs to Buy and Hold for Life if the Market Crashes
11:06am, Thursday, 11'th Dec 2025
Dividend ETFs may be the best investment you can make today.
Pharma ETFs to Gain From Landmark UK-US Zero-Tariff Deal
02:41pm, Tuesday, 09'th Dec 2025
Pharma ETFs like IHE are poised to surge as the UK-US zero-tariff deal raises UK drug prices and strengthens major U.S. players' outlook.
IHE: Pharma Powerhouse ETF Despite High Fees And Valuation
09:40am, Thursday, 27'th Nov 2025
iShares U.S. Pharmaceuticals ETF is rated a buy, driven by strong growth and dividends from top holdings like Eli Lilly, JNJ, and Merck. IHE's top holdings, particularly LLY, JNJ, and MRK, offer diver
Pharma ETFs in Spotlight Following Robust Q3 Earnings Results
09:01am, Friday, 14'th Nov 2025
Pharma ETFs like IHE and PPH are rallying as strong Q3 earnings across major pharmaceutical companies lift sector sentiment.
Does Trump's MFN Policy Put Pharma ETFs in the Crosshairs?
08:50am, Monday, 10'th Nov 2025
Pharma giants Eli Lily ( LLY ) and Novo Nordisk ( NVO ) have signed deals with U.S. President Donald Trump to slash the prices of some of their obesity drugs, including upcoming pills, as per a White
Pharma ETF (IHE) Hit a 52-Week High
10:01am, Wednesday, 05'th Nov 2025
Investors seeking momentum may have iShares U.S. Pharmaceuticals ETF IHE on radar now. The fund recently hit a new 52-week high.
4 Reasons to Buy Pharma ETFs Now for a Healthy Portfolio
08:01am, Monday, 06'th Oct 2025
Pharma's Trump-Pfizer boost sparks momentum, making ETFs PPH, IHE, PJP & XPH attractive for defensive, undervalued growth plays.
Trump announces 100% tariffs on pharmaceutical drugs, beginning October 1
01:22pm, Friday, 26'th Sep 2025
President Donald Trump said Thursday that he will put import taxes of 100% on pharmaceutical drugs, 50% on kitchen cabinets and bathroom vanities, 30% on upholstered furniture and 25% on heavy trucks
Trump Slams 100% Tariff on Imported Drugs: Pharma ETFs Take a Hit
10:26am, Friday, 26'th Sep 2025
Trump's 100% tariff on imported drugs jolts markets, slamming pharma giants and dragging ETFs like XPH, FTXH, IHE, and PPH lower.
Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)?
07:21am, Tuesday, 02'nd Sep 2025
Looking for broad exposure to the Healthcare - Pharma segment of the equity market? You should consider the iShares U.S. Pharmaceuticals ETF (IHE), a passively managed exchange traded fund launched on
Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)?
07:21am, Tuesday, 01'st Jul 2025
The iShares U.S. Pharmaceuticals ETF (IHE) was launched on 05/01/2006, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Pharma segment of the equity
